chr10-123009067-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001609.4(ACADSB):c.38G>A(p.Arg13Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.362 in 1,546,378 control chromosomes in the GnomAD database, including 106,321 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_001609.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACADSB | NM_001609.4 | c.38G>A | p.Arg13Lys | missense_variant | 1/11 | ENST00000358776.7 | NP_001600.1 | |
ACADSB | NM_001330174.3 | c.-168G>A | 5_prime_UTR_variant | 1/10 | NP_001317103.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACADSB | ENST00000358776.7 | c.38G>A | p.Arg13Lys | missense_variant | 1/11 | 1 | NM_001609.4 | ENSP00000357873 | P1 | |
ACADSB | ENST00000368869.8 | c.-164G>A | splice_region_variant, 5_prime_UTR_variant | 1/10 | 2 | ENSP00000357862 |
Frequencies
GnomAD3 genomes AF: 0.298 AC: 45237AN: 151960Hom.: 7985 Cov.: 32
GnomAD3 exomes AF: 0.310 AC: 45435AN: 146504Hom.: 7805 AF XY: 0.311 AC XY: 24198AN XY: 77696
GnomAD4 exome AF: 0.369 AC: 513968AN: 1394300Hom.: 98339 Cov.: 45 AF XY: 0.365 AC XY: 251287AN XY: 687992
GnomAD4 genome AF: 0.297 AC: 45241AN: 152078Hom.: 7982 Cov.: 32 AF XY: 0.297 AC XY: 22051AN XY: 74316
ClinVar
Submissions by phenotype
Deficiency of 2-methylbutyryl-CoA dehydrogenase Benign:3
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 14, 2021 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Mar 06, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 03, 2015 | This variant is associated with the following publications: (PMID: 17143180) - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at